KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Non Operating Income: 2010-2024

Historic Non Operating Income for Novavax (NVAX) over the last 14 years, with Dec 2024 value amounting to $40.4 million.

  • Novavax's Non Operating Income fell 42.36% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.3 million, marking a year-over-year increase of 15.62%. This contributed to the annual value of $40.4 million for FY2024, which is 6.72% up from last year.
  • Latest data reveals that Novavax reported Non Operating Income of $40.4 million as of FY2024, which was up 6.72% from $37.9 million recorded in FY2023.
  • Novavax's 5-year Non Operating Income high stood at $40.4 million for FY2024, and its period low was -$6.8 million during FY2021.
  • Over the past 3 years, Novavax's median Non Operating Income value was $37.9 million (recorded in 2023), while the average stood at $29.8 million.
  • Per our database at Business Quant, Novavax's Non Operating Income skyrocketed by 104,753.85% in 2020 and then crashed by 150.22% in 2021.
  • Yearly analysis of 5 years shows Novavax's Non Operating Income stood at $13.6 million in 2020, then slumped by 150.22% to -$6.8 million in 2021, then skyrocketed by 260.53% to $11.0 million in 2022, then soared by 245.48% to $37.9 million in 2023, then climbed by 6.72% to $40.4 million in 2024.